ArticleNeurology2025
Incidence and Determinants of Nonfocal Transient Neurologic Attacks: The Rotterdam Study.
Article in Neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectivesRecent literature suggests no elevated risk of cardiovascular disease in patients having nonfocal transient neurologic attacks (TNAs), yet the origin of these attacks remains unclear. Therefore, we investigated their incidence and potential risk factors in a prospective cohort study, hypothesizing associations with cardiovascular risk factors.
methodsWithin the Dutch population-based Rotterdam Study, community-living individuals aged 45 years or older underwent assessment for demographic and cardiovascular risk factors in study cohorts initiated in 1990, 2000, and 2006. Participants were subsequently followed until January 1, 2021, for disease incidence through automated linkage of the study database with medical records from participants' general practitioners. For this study, participants free from TNA at baseline were selected and followed up for the outcome of a nonfocal TNA. The risk of nonfocal TNA was determined through age-specific incidence rates (IRs). Potential risk factors of nonfocal TNA were identified using cause-specific, multivariable, Cox proportional hazard modeling accounting for age, sex, education (university or higher vocational vs lower education level), cardiovascular risk factors, ultrasound markers of carotid atherosclerosis, antithrombotic medication use, and a history of vascular diseases. Sensitivity analyses consisted of conducting this regression among participants without any history of vascular disease at study entrance.
resultsAfter 204,474 person-years of follow-up in 14,096 participants (mean [SD] age 65.5 [10.3] years, 59.0% female), 518 index nonfocal TNAs (3.7%) occurred. The incidence of nonfocal TNA increased with age, with an IR in those aged between 55 and 59 years of 65.5 (95% CI 33.6-116.2) per 100,000 person-years of follow-up to 424.0 (95% CI 348.0-512.0) in those aged 85 years or older. Older age (hazard ratio [HR] 1.08, 95% CI 1.07-1.09), a lower education level (HR 1.62, 95% CI 1.15-2.29), plaque presence on carotid ultrasound (HR 0.80, 95% CI 0.65-1.00), and the use of antithrombotics (HR 0.59, 95% CI 0.39-0.90) were all independently associated with the risk of nonfocal TNA. After restricting analyses to the 12,499 individuals without history of vascular disease, only the associations of age and a higher maximum attained education level with the risk of nonfocal TNA remained statistically significant. DISCUSSION: Nonfocal TNAs predominantly affect older adults and those with lower educational attainment, suggesting that these attacks originate from socioeconomic determinants rather than from established cardiovascular risk factors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.